Sartorius Stedim Biotech SA (SDMHF)
223.00
+13.00
(+6.19%)
USD |
OTCM |
Sep 16, 16:00
Sartorius Stedim Biotech Enterprise Value : 24.22B for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 24.22B |
| September 15, 2026 | 22.96B |
| September 14, 2026 | 22.96B |
| September 11, 2026 | 23.92B |
| September 10, 2026 | 23.92B |
| September 09, 2026 | 24.81B |
| September 08, 2026 | 24.81B |
| September 04, 2026 | 24.81B |
| September 03, 2026 | 24.81B |
| September 02, 2026 | 24.81B |
| September 01, 2026 | 24.81B |
| August 31, 2026 | 24.81B |
| August 28, 2026 | 24.81B |
| August 27, 2026 | 23.65B |
| August 26, 2026 | 23.65B |
| August 25, 2026 | 23.65B |
| August 24, 2026 | 23.65B |
| August 21, 2026 | 23.65B |
| August 20, 2026 | 23.65B |
| August 19, 2026 | 23.65B |
| August 18, 2026 | 23.65B |
| August 17, 2026 | 22.81B |
| August 14, 2026 | 22.81B |
| August 13, 2026 | 22.09B |
| August 12, 2026 | 22.71B |
| Date | Value |
|---|---|
| August 11, 2026 | 22.18B |
| August 10, 2026 | 22.18B |
| August 07, 2026 | 22.18B |
| August 06, 2026 | 22.18B |
| August 05, 2026 | 22.08B |
| August 04, 2026 | 22.08B |
| August 03, 2026 | 22.08B |
| July 31, 2026 | 21.30B |
| July 30, 2026 | 21.30B |
| July 29, 2026 | 21.30B |
| July 28, 2026 | 21.30B |
| July 27, 2026 | 21.30B |
| July 24, 2026 | 21.30B |
| July 23, 2026 | 21.21B |
| July 22, 2026 | 21.16B |
| July 21, 2026 | 21.16B |
| July 20, 2026 | 23.49B |
| July 17, 2026 | 23.49B |
| July 16, 2026 | 23.49B |
| July 15, 2026 | 23.49B |
| July 14, 2026 | 23.49B |
| July 13, 2026 | 23.49B |
| July 10, 2026 | 23.04B |
| July 09, 2026 | 22.08B |
| July 08, 2026 | 22.08B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 45.53B |
| Bio-Rad Laboratories, Inc. | 9.885B |
| Bruker Corp. | 10.90B |
| Azenta, Inc. | 1.179B |
| Danaher Corp. | 169.98B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 108.95M |
| Revenue (Quarterly) | 890.29M |
| Total Expenses (Quarterly) | 782.15M |
| EPS Diluted (Quarterly) | 1.111 |
| Gross Profit Margin (Quarterly) | 46.86% |
| Profit Margin (Quarterly) | 12.24% |
| Earnings Yield | 1.57% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 1.836 |